# The Clinical Trial of CL2020 Cells for Neonatal Hypoxic Ischemic Encephalopathy

> **NCT04261335** · PHASE1 · COMPLETED · sponsor: **Nagoya University** · enrollment: 9 (actual)

## Conditions studied

- Hypoxia-Ischemia, Brain

## Interventions

- **BIOLOGICAL:** CL2020 cells

## Key facts

- **NCT ID:** NCT04261335
- **Lead sponsor:** Nagoya University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-04
- **Primary completion:** 2021-09-29
- **Final completion:** 2022-12-12
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04261335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04261335, "The Clinical Trial of CL2020 Cells for Neonatal Hypoxic Ischemic Encephalopathy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04261335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*